I have seen a few times CDEL manipulation skip the ask pushing higher with no buyers whenever they want. That is why I am not taken a change waiting for the bottom without shares. I have another 100k on the side to buy more. If they bring it lower I will be very happy man. LOL:)))
You need to go back to chart school you have no idea whats coming RVVTF Phase 3 drug with very low side affects to treat large patient populations of Covid-19.Gap filled perfectly at .2003 Wave 5 Fib RVVTF price target $10.00 by end of summer. My friend is a Pharma analyst at Goldman Sachs. He says if Approval on RVVTF Bucillamine comes for Covid-19. At hits current market cap. The price valuations will between $20.00-$30.00
News 
Market Data 
Discover 
